All systems operational
Q3 2025

Clinical signficance of human leucocytic antigen (HLA-B27) in patients with early and late-onset axial spondyloarthritis

Ebru Yilmaz · Özlem Toluk
10.1016/j.ejr.2024.10.001 388 Views 6 Citations
6
Citations
388
Views
Abstract not available for this publication.
Cite this Article (APA)
Ebru, Y., Özlem, T. (2025). Clinical signficance of human leucocytic antigen (HLA-B27) in patients with early and late-onset axial spondyloarthritis. Egyptian Rheumatologist. https://doi.org/10.1016/j.ejr.2024.10.001
Related Papers
Spirulina as a promising agent in rheumatoid arthritis with no observed hepatic injury
Noha A. Fadel; Maha M. Aziz; Ghada M. Shafey; Rasha R. Rashed; Heba A. Gheita · 2024
7
cites
388
A single-center experience: Enteropathic arthritis in inflammatory bowel diseases
Barış Çabuk; Dilara Bulut Gökten; Tevfik Solakoğlu; Rafet Mete; Nurten Türkel Kü · 2024
6
cites
384
Risk of mortality among people with rheumatoid arthritis and depression
Srikanta Banerjee; Jagdish Khubchandani; Latrice Noonan; Kavita Batra; Ayana Pai · 2024
6
cites
388
Effect of first week-intermittent fasting during Ramadan on the severity of neuropsychiatric symptom…
Mona Hussein; Wael Fathy; Mohamed Abdelghaffar; Mohamed T. Hegazy; Doaa A. Teleb · 2024
5
cites
388
Trunk position sense, spine posture and static postural sway in axial spondyloarthritis patients: Re…
Yasemin Mirza; Bahar Anaforoğlu; Tülin Düger; Adem Küçük · 2024
4
cites
389
Access
View Full Text via DOI
Published in
ISSN 1110-1164
Quartile Q3
AMS Score 78
Field Medicine & Health Sciences
Publisher Elsevier / Egyptian Society for Rhe
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2025
Language English
Added 27 Jul 2026